APOA1 and atherosclerosis: Both the expression of ATP-binding cassette transporter A1 (ABCA1) and its binding to apolipoprotein A-I (ApoA1) of high-density lipoproteins (HDLs) are reduced in human SMCs, with this impairment appearing to be more pronounced in the advanced stages of atherosclerosis (121).